Nature Communications · 2022 · 28 citations · 31 references
Life SciencesImmunologyOncologyAdaptive ImmunityCancer ImmunologyImmunotherapyAdaptive Immune ResponsesAntigen RecognitionCancer ImmunotherapyCell-mediated ImmunityChimeric Antigen Receptor T-cell TherapyT Cell BiologyClonal Expansion Of LymphocytesHost Immune SuppressionImmune Suppression MechanismsT Cell Clonal ExpansionT Cell Receptor TherapyT-cell Immune ResponsesT-cell Mediated ImmunityT-cell Mediated Responses
Abstract The success of chimeric antigen receptor (CAR) T cells in treating B cell malignancies comes at the price of eradicating normal B cells. Even though T cell malignancies are aggressive and treatment options are limited, similar strategies for T cell malignancies are constrained by the severe immune suppression arising from bystander T cell aplasia. Here, we show the selective killing of malignant T cells without affecting normal T cell-mediated immune responses in vitro and in a mouse model of disseminated leukemia. Further, we develop a CAR construct that carries the single chain variable fragment of a subtype-specific antibody against the variable TCR β-chain region. We demonstrate that these anti-Vβ8 CAR-T cells are able to recognize and kill all Vβ8 + malignant T cells that arise from clonal expansion while sparing malignant or healthy Vβ8 − T cells, allowing sufficient T cell-mediated cellular immunity. In summary, we present a proof of concept for a selective CAR-T cell therapy to eradicate T cell malignancies while maintaining functional adaptive immunity, which opens the possibility for clinical development.
31
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner et al. · New England Journal of Medicine · 2018 · 5.6K citations · Full text
Medicine, Hematology, Oncology +17
Activating Mutations of <i>NOTCH1</i> in Human T Cell Acute Lymphoblastic Leukemia
Andrew P. Weng, Adolfo A. Ferrando, Woojoong Lee et al. · Science · 2004 · 2.7K citations
Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
Haidong Tang, Yang Wang, Lukasz K. Chlewicki et al. · Cancer Cell · 2016 · 482 citations · Full text
Medicine, Immunology, Oncology +16
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
Diogo Gomes‐Silva, Madhuwanti Srinivasan, Sandhya Sharma et al. · Blood · 2017 · 463 citations · Full text
Life Sciences, Immunology, Oncology +16